Pathlight Investors’s Novartis NVS Stock Holding History

Pathlight Investors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$408K	Buy	+5,240	New	+$408K	0.34%	54

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Pathlight Investors's NVS Position: Q4 2018 in Review

Pathlight Investors opened a new position in Novartis (NVS) in Q4 2018: 5,240 shares worth $408K. The stake represents 0.34% of the portfolio and ranks #54 among its holdings.

1,088 funds tracked by Wall St. Rank hold NVS as of Q4 2018.

Pathlight Investors held 5,240 shares of Novartis worth $408K as of Q4 2018.
Novartis was a new Pathlight Investors position in Q4 2018.
Novartis made up 0.34% of Pathlight Investors's portfolio in Q4 2018, its #54 holding.
1,088 funds tracked by Wall St. Rank held Novartis as of Q4 2018.

Based on Pathlight Investors's 13F filing for Q4 2018, filed 19 Feb 2019.